Results of the Healthcare division
Division in the group
32%
Healthcare
Distribution based on sales
46%
Diagnostic imaging
54%
Surgical & Modality
54%
Surgical & Modality
Sales
In millions of euro
262
2020
262
2021
342
2022
Gross profit
In millions of euro
96
2020
87
2021
116
2022
EBITDA
In millions of euro
35
2020
22
2021
38
2022
Comments on the results
The Healthcare division posted continued solid order intake following the strong order intake in 2021. Although the demand for our healthcare products was remarkably resilient throughout the pandemic in 2020 and 2021, we saw a gradual resumption of healthcare investments in Diagnostic Imaging and Surgical & Modality in 2022.